Preguntas frecuentes
Glosario

Cerrar

Preguntas frecuentes

Why are some conditions more suitable for gene and cell therapies than others?

There is an approved treatment available for my condition - why can't I receive it?

How to look for approved medicines?

How are medicines developed and approved?

Ver todas las preguntas frecuentes

Cerrar

Glosario

Adeno-associated virus (AAV)

Adult stem cells

Chimeric Antigen Receptor (CAR)

Ver el glosario completo

Connecting young people with Type 1 Diabetes through science

Related topics:
Diabetes Cell Therapy Current and Potential Uses Embryonic Stem Cells Patient Involvement Reprogramming Research Stem Cell News

ISLET is an EU-funded Horizon 2020 project that aims to make advanced stem cell therapy for Type 1 Diabetes (T1D) available in everyday healthcare.

IDF Europe is the European branch of the International Diabetes Foundation, who aim to reduce the prevalence of diabetes, improve the quality of life for people living with diabetes, and increase the voice of people living with diabetes in healthcare conversations.

Cartoon graphic of two figures hugging. One wears an insulin patch on their arm.

In 2022, a dialogue was established between scientists in ISLET and IDF Europe's YOURAH group of young people living with diabetes. These conversations explored ways of broadening the understanding of scientific research conducted by ISLET, and to provide the scientists with insight into the experience of living with diabetes. This post reflects some of the main areas of discussion.

Connecting young people with Type 1 Diabetes through science

Related pages

Screenshot of diabetes video

Video: Diabetes and Stem Cells

Resource

Temas relacionados Diabetes Cell Therapy Explore Stem Cells

A diabetic injects himself using an insulin pen

Diabetes: how could stem cells help?

Hoja informativa

Temas relacionados Diabetes Current and Potential Uses Factsheets

¿Le pareció útil el contenido de esta página? Envianos tus comentarios